BIOWISDOM AND LINGUAMATICS TO PROVIDE AN ONTOLOGY AND NLP-BASED TEXT MINING APPLICATION TO ASTRAZENECA.

BIOWISDOM AND LINGUAMATICS TO PROVIDE AN ONTOLOGY AND NLP-BASED TEXT MINING APPLICATION TO ASTRAZENECA.

(PRWEB) October 26, 2003 --The leading expert in ontology, BioWisdom has made available components of their drug discovery ontology for use in a linguistic analysis tool provided by Linguamatics, leading players in Natural Language Processing (NLP). The sophisticated combination of ontology with linguistic analysis provides for substantially enhanced search performance over other text mining approaches and provides a significant enhancement to AstraZenecas text mining capabilities.

James Fickett, Global Director of Bioinformatics at AstraZeneca, commenting on the application said, The natural language processing application, Linguamatics, with biomedical domain knowledge incorporated through the inclusion of the BioWisdom ontologies, has greatly enhanced our ability to extract specific information from the literature."
Gordon Smith Baxter, CEO of BioWisdom, commenting on the project said,
"This is an excellent example of how ontology can be used to enhance a range of applications in drug discovery. This type of partnership fits perfectly with our business vision to deliver best of breed solutions that are enabled by knowledge of the life science domain."

Roger Hale, COO Linguamatics, commenting on the system said,
"Linguamatics interactive text mining system is a powerful tool for information discovery. By integrating BioWisdoms ontology as a specialist knowledge source, we have a world-class system for analysing the life sciences literature."

About BioWisdom Ltd
BioWisdom Ltd., headquartered in Cambridge UK, and established in September 2000, is a world leader in Ontology, a branch of science that seeks to enhance communication between people and improve access to information. The company focuses on pharmaceutical R&D, where it's technology is used in a wide variety of applications, relevant to the discovery and development of novel drug therapies.

About Linguamatics Ltd
Linguamatics Ltd, headquartered in Cambridge UK, and established in 2001, is at the forefront of natural language processing, specialising in ontology-based systems for processing text and speech. Linguamatics produces general purpose tools for text mining and spoken dialogue, which can be customised to particular applications using real-world knowledge encapsulated in ontologies. Applications range from pathway discovery in biomedical literature to voice control of in-car systems.

About AstraZeneca
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $17.8 billion and leading positions in sales of gastrointestinal, oncology, cardiovascular, neuroscience and respiratory products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index.
###
For further information, please contact:

Gordon Smith Baxter, CEOBioWisdom LtdTel: +44 (0)1223 492100Email: gordon.baxter@biowisdom.comWWW: http://www.biowisdom.com   Roger Hale, COOLinguamatics LtdTel: +44 (0)1223 421360Email: roger.hale@linguamatics.comWWW: http://www.linguamatics.com